Welcome to The Cannabis Recap?your go-to source for actionable insights on the rapidly evolving cannabis industry. My goal is to provide context behind the news, go beyond current events, and keep you informed on all things cannabis. I investigate hundreds of articles each month to bring you the most relevant, insightful information on the global cannabis market. My newsletter is a carefully curated collection of the latest industry trends, research, and regulatory changes.
Join me on this journey as I explore the ever-changing cannabis landscape and provide you with the information you need to stay?informed.
- Is cannabis a gateway drug??New research from CU Boulder challenges the idea of cannabis as a gateway drug. The study analyzed over 4,000 twins from Colorado and Minnesota and found no evidence linking cannabis legalization to increases in substance use disorders or use of other illicit drugs among adults. The researchers compared twins living in states where cannabis is legal to those where it remains illegal and found no benefit to psychosocial health from legalization. Interestingly, twins in legal states showed fewer symptoms of an alcohol use disorder, suggesting cannabis may be a safer alternative. While the study did not look at adolescents, it's a valuable resource for debunking the stigma around cannabis use leading to adult psychiatric and psychosocial outcomes.?Study reference
?
- Interesting study on Indica VS Sativa?- I came across a study that looked at the effects of?strain classes "sativa" or "indica" (and the presence of?terpenes)?and how their effects are perceived. The researchers asked regular cannabis users to report on their cannabis use and how it made them feel, including their pain levels, arousal levels, and any negative effects. They then looked at the classification of the cannabis strains used and the terpenes present in those strains. Whilst I don't think the study answered all my questions, it did find that strains classified as "indica" tended to produce more calming effects compared to other strains, while strains with a high level of a terpene called caryophyllene tended to produce more pain and negative effects. Strains with high levels of terpene called pinene tended to produce fewer negative effects.?Study reference
- Cannabis and Sleep - what is going on??Results from a recent study comparing a cannabis oral preparation and placebo dominated that the cannabis preparation in fact decreased sleep quality compared to the placebo - let’s not through the baby out with the bath water here. Whilst I’m yet to see sufficient clinical data on cannabis and sleep (please share if you have), I do think it’s important to also assess the clinical efficacy of whole plant/full spectrum products - not only isolated compounds. Whilst this study does not specify if the THC and CBD were isolated, terpenes were also not mentioned. In comparison, I also read a report on patients with moderate-to-severe anxiety experiencing symptom improvements (including sleep) and better cognitive performance following the daily administration of full-spectrum cannabidiol (CBD) extracts, according to open-label trial data published in the journal Communications Medicine. References?1
?and?2
Cannabis consultant and Tourette’s Syndrome advocate
1 年Thank you for your dedication Adam to getting the most current information to the community.
Healthcare Lending Specialist at Healthcare Home Loans
1 年This is awesome ??